Focused Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-509
Closed -$1.13M 236
2024
Q3
$1.13M Buy
+509
New +$10.6K 0.15% 69
2024
Q1
Sell
-630
Closed -$9.09K 701
2023
Q4
$9.09K Sell
630
-16
-2% -$218 ﹤0.01% 569
2023
Q3
$11.2K Buy
646
+2
+0.3% +$42 ﹤0.01% 506
2023
Q2
$13.4K Buy
644
+3
+0.5% +$65 ﹤0.01% 496
2023
Q1
$15.1K Buy
641
+2
+0.3% +$54 ﹤0.01% 482
2022
Q4
$17.8K Buy
639
+2
+0.3% +$51 ﹤0.01% 441
2022
Q3
$15K Buy
637
+2
+0.3% +$60 ﹤0.01% 445
2022
Q2
$21K Sell
635
-5
-0.8% -$175 ﹤0.01% 404
2022
Q1
$22K Buy
640
+2
+0.3% +$68 ﹤0.01% 432
2021
Q4
$19K Buy
638
+1
+0.2% +$33 ﹤0.01% 497
2021
Q3
$21K Sell
637
-38
-6% -$1.22K ﹤0.01% 502
2021
Q2
$20K Buy
+675
New +$22.2K ﹤0.01% 512

Other funds holding OGN

Focused Wealth Management's OGN Position: Q4 2024 in Review

Focused Wealth Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 509 shares — an estimated $1.13M sold.

Focused Wealth Management first reported a position in OGN in Q2 2021 and held it in 12 quarters. The position peaked at $1.13M in Q3 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Focused Wealth Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Focused Wealth Management sold 509 Organon & Co shares in Q4 2024, an estimated $1.13M.
  • Focused Wealth Management first reported a position in Organon & Co in Q2 2021 and held it in 12 quarters.
  • Focused Wealth Management's Organon & Co position peaked at $1.13M in Q3 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Focused Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.